260 CEO & leadership appearances, 2009–2026 · Novo 165 · Lilly 95
Why the archive exists: across every company and product, GLP-1 sales overtook insulin in Q4 2021.
Where the money is now: GLP-1 sales by indication – diabetes vs the newer obesity wave.
Part of MidgardFinance's obesity & diabetes coverage · see the obesity drug hub, the type‑2 diabetes hub and the Novo Nordisk timeline · 259 transcripts indexed so far · videos hosted on YouTube.